A new study suggests that Alzheimer's disease may be detected by brain imaging more than seven years earlier than previously ...
The study suggests that the gold standard for imaging in Alzheimer's disease (amyloid-PET) has not been sensitive enough to ...
Seventeen clinical scenarios developed for which amyloid or tau PET may be considered. HealthDay News — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) ...
Pharmaceutical Technology on MSN
Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval
Lantheus's radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) ...
Lantheus Holdings (LNTH) wins FDA approval for Tauklarify, a radiodiagnostic agent designed to identify tau pathology in ...
NeuroQuant ® PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET ® aids physicians in the evaluation of patient pathologies and the clinical interpretation of PET performed for the ...
A PET imaging study reveals 65% of late-onset psychosis patients have tau protein accumulation linked to dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results